357 related articles for article (PubMed ID: 19475479)
1. Usefulness of immunohistochemistry for differential diagnosis between benign and malignant breast lesions.
Moriya T; Kanomata N; Kozuka Y; Fukumoto M; Iwachido N; Hata S; Takahashi Y; Miura H; Ishida K; Watanabe M
Breast Cancer; 2009; 16(3):173-8. PubMed ID: 19475479
[TBL] [Abstract][Full Text] [Related]
2. Papillary neoplasia of the breast: immunohistochemically defined myoepithelial cells in the diagnosis of benign and malignant papillary breast neoplasms.
Raju UB; Lee MW; Zarbo RJ; Crissman JD
Mod Pathol; 1989 Nov; 2(6):569-76. PubMed ID: 2479944
[TBL] [Abstract][Full Text] [Related]
3. Metaplastic spindle cell breast tumors arising within papillomas, complex sclerosing lesions, and nipple adenomas.
Gobbi H; Simpson JF; Jensen RA; Olson SJ; Page DL
Mod Pathol; 2003 Sep; 16(9):893-901. PubMed ID: 13679453
[TBL] [Abstract][Full Text] [Related]
4. The role of immunohistochemistry in the differential diagnosis of papillary lesions of the breast.
Tse GM; Tan PH; Moriya T
J Clin Pathol; 2009 May; 62(5):407-13. PubMed ID: 19126567
[TBL] [Abstract][Full Text] [Related]
5. Solid papillary ductal carcinoma in situ versus usual ductal hyperplasia in the breast: a potentially difficult distinction resolved by cytokeratin 5/6.
Rabban JT; Koerner FC; Lerwill MF
Hum Pathol; 2006 Jul; 37(7):787-93. PubMed ID: 16784976
[TBL] [Abstract][Full Text] [Related]
6. Ductal carcinoma in situ with spindle cells: a potential diagnostic pitfall in the evaluation of breast lesions.
Tan PH; Lui GG; Chiang G; Yap WM; Poh WT; Bay BH
Histopathology; 2004 Oct; 45(4):343-51. PubMed ID: 15469472
[TBL] [Abstract][Full Text] [Related]
7. Double immunostaining with p63 and high-molecular-weight cytokeratins distinguishes borderline papillary lesions of the breast.
Ichihara S; Fujimoto T; Hashimoto K; Moritani S; Hasegawa M; Yokoi T
Pathol Int; 2007 Mar; 57(3):126-32. PubMed ID: 17295644
[TBL] [Abstract][Full Text] [Related]
8. Observer variability in the histopathological reporting of core biopsies of papillary breast lesions is reduced by the use of immunohistochemistry for CK5/6, calponin and p63.
Douglas-Jones A; Shah V; Morgan J; Dallimore N; Rashid M
Histopathology; 2005 Aug; 47(2):202-8. PubMed ID: 16045782
[TBL] [Abstract][Full Text] [Related]
9. [Diagnostic immunohistochemistry of breast epithelial lesions].
Balaton AJ; Guinebretière JM; Penault-Llorca F
Ann Pathol; 2003 Dec; 23(6):570-81. PubMed ID: 15094595
[TBL] [Abstract][Full Text] [Related]
10. Benign myoepithelioma of the breast: origin and development.
Hikino H; Nagaoka S; Miura H; Kurosumi M
Pathol Int; 2009 Jun; 59(6):422-6. PubMed ID: 19490475
[TBL] [Abstract][Full Text] [Related]
11. The role of nipple discharge cytology in the diagnosis of breast disease: a study of 1948 nipple discharge smears from 1530 patients.
Gupta RK; Gaskell D; Dowle CS; Simpson JS; King BR; Naran S; Lallu S; Fauck R
Cytopathology; 2004 Dec; 15(6):326-30. PubMed ID: 15606366
[TBL] [Abstract][Full Text] [Related]
12. Use of immunohistochemistry in diagnosis of breast epithelial lesions.
Bhargava R; Dabbs DJ
Adv Anat Pathol; 2007 Mar; 14(2):93-107. PubMed ID: 17471116
[TBL] [Abstract][Full Text] [Related]
13. [Histopathological diagnosis of papillary lesion of the breast].
Akiyama F; Sakamoto G
Gan To Kagaku Ryoho; 1995 Apr; 22 Suppl 1():32-5. PubMed ID: 7747989
[TBL] [Abstract][Full Text] [Related]
14. Myoepithelial cells in solid variant of intraductal papillary carcinoma of the breast: a potential diagnostic pitfall and a proposal of an immunohistochemical panel in the differential diagnosis with intraductal papilloma with usual ductal hyperplasia.
Moritani S; Ichihara S; Kushima R; Okabe H; Bamba M; Kobayashi TK; Hattori T
Virchows Arch; 2007 May; 450(5):539-47. PubMed ID: 17377808
[TBL] [Abstract][Full Text] [Related]
15. Squamous cell carcinoma in situ of the breast: a light microscopic and immunohistochemical study of a previously undescribed lesion.
Hayes MM; Peterse JL; Yavuz E; Vischer GH; Eusebi V
Am J Surg Pathol; 2007 Sep; 31(9):1414-9. PubMed ID: 17721198
[TBL] [Abstract][Full Text] [Related]
16. A useful immunohistochemical approach to evaluate intraductal proliferative lesions of the breast and to predict their prognosis.
Omi Y; Yamamoto T; Okamoto T; Obara T; Kobayashi M
Histol Histopathol; 2011 Jan; 26(1):79-86. PubMed ID: 21117029
[TBL] [Abstract][Full Text] [Related]
17. New trends of immunohistochemistry for making differential diagnosis of breast lesions.
Moriya T; Kasajima A; Ishida K; Kariya Y; Akahira J; Endoh M; Watanabe M; Sasano H
Med Mol Morphol; 2006 Mar; 39(1):8-13. PubMed ID: 16575508
[TBL] [Abstract][Full Text] [Related]
18. Adenomyoepithelial tumours and myoepithelial carcinomas of the breast--a spectrum of monophasic and biphasic tumours dominated by immature myoepithelial cells.
Hungermann D; Buerger H; Oehlschlegel C; Herbst H; Boecker W
BMC Cancer; 2005 Jul; 5():92. PubMed ID: 16050957
[TBL] [Abstract][Full Text] [Related]
19. Ductal adenoma of the breast: immunohistochemistry of two cases.
Terada T
Pathol Int; 2008 Dec; 58(12):801-5. PubMed ID: 19067857
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of CD56 and CD57 immunostainings for discrimination between endocrine ductal carcinoma in situ and intraductal papilloma.
Tajima S; Maeda I; Kanemaki Y; Nakajima Y; Tatsunami S; Fukuda M; Takagi M
Pathol Int; 2010 Jun; 60(6):459-65. PubMed ID: 20518901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
